MYD88 and diffuse large B-cell lymphoma: ND-2158 and ND-2110 inhibited IRAK4 and NF-κB activity in activated B cell–like (ABC) subtype of diffuse large B cell lymphoma (DLBCL) cell lines with L265P mutation in MyD88.